title: Fluorescein angiography and visual acuity in active uveitis with Behçet disease.
abstract: OBJECTIVE
  To determine the association of fluorescein angiography characteristics with visual acuity and visual loss during medical treatment in patients with Behçet uveitis.
  
  
  METHODS
  Ninety-three eyes from 69 Behçet patients with active panuveitis underwent fluorescein angiography, and the characteristic findings by angiography were determined. The patients were followed with immunomodulatory treatment.
  
  
  RESULTS
  Diffuse vascular leakage (73.4%), diffuse macular leakage (66.0%), and disc leakage (52.7%) were the predominant angiographic findings on fluorescein angiography. Multivariate logistic regression analysis revealed that a macular window defect and disc neovascularization on fluorescein angiography were associated with poor visual acuity (<or= 20/200) (p < .05). The presence of macular ischemia on fluorescein angiography was significantly associated with the risk of visual loss (<or= 20/200) at 48 months post-treatment (p < .05).
  
  
  CONCLUSIONS
  These results suggest that fluorescein angiography may be helpful for predicting visual prognosis for Behçet patients with panuveitis.
authors.affiliation: Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.
authors.forename: Hyeong Gon
authors.initials: HG
authors.lastname: Yu
authors.forename: Moon Jung
authors.initials: MJ
authors.lastname: Kim
authors.forename: Frederick Sewoong
authors.initials: FS
authors.lastname: Oh
mesh_terms: D000328:Adult; D000368:Aged; D001528:Behcet Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015864:Panuveitis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D012189:Retrospective Studies; D012307:Risk Factors; D014786:Vision Disorders / Q000503:physiopathology*; D014792:Visual Acuity / Q000502:physiology*; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents